Synthetic Data's Future
Synthetic data holds the potential to reduce animal experimentation by augmenting existing data, but high-quality animal data is essential for its success. The future of drug development is poised for transformation as machine learning becomes increasingly integrated into biology, with expectations that a larger percentage of top machine learning talent will gravitate towards this field. Immunoise aims to leverage these advancements to develop innovative treatments for various diseases in the coming years.In this clip
From this podcast
The AI Podcast
Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
Related Questions